Richard M. Toselli is CEO and CMO of INVIVO THERAPEUTICS HOLDINGS CORP.. Currently has a direct ownership of 6,201 shares of NVIV, which is worth approximately $2,294. The most recent transaction as insider was on Dec 21, 2021, when has been sold 16 shares (Common Stock) at a price of $0.54 per share, resulting in proceeds of $9. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.2K
0% 3M change
0% 12M change
Total Value Held $2,294

Richard M. Toselli Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2021
SELL
Payment of exercise price or tax liability
$9 $0.54 p/Share
16 Reduced 0.26%
6,201 Common Stock
Jun 21 2021
SELL
Payment of exercise price or tax liability
$16 $0.74 p/Share
21 Reduced 0.34%
6,217 Common Stock
Dec 21 2020
SELL
Payment of exercise price or tax liability
$10 $0.6 p/Share
16 Reduced 0.26%
6,238 Common Stock
RMT

Richard M. Toselli

CEO and CMO
Cambridge, MA

Track Institutional and Insider Activities on NVIV

Follow INVIVO THERAPEUTICS HOLDINGS CORP. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVIV shares.

Notify only if

Insider Trading

Get notified when an Invivo Therapeutics Holdings Corp. insider buys or sells NVIV shares.

Notify only if

News

Receive news related to INVIVO THERAPEUTICS HOLDINGS CORP.

Track Activities on NVIV